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ABSTRACT 
Towards the development of microparticulate carriers for nasal administration, N-trimethyl 
chitosan chloride (TMC) of low molecular weight (LMW) and high molecular weight (HMW) 
and low degree of quaternisation (16% and 27% respectively) was co-formulated into 
microparticles comprising of dipalmatoylphosphatidylcholine (DPPC) and poly(lactic-co-
glycolic) acid (PLGA) via the spray-drying technique. The chitosan derivatives were 
characterised by means of nuclear magnetic resonance (NMR), differential scanning calorimetry 
(DSC) and fourier-transfrom infrared (FTIR) spectroscopy. The size and morphology of the 
produced microparticles were assessed by scanning electron microscopy (SEM), whereas their 
mucoadhesive properties were investigated by means of atomic force microscopy-force 
spectroscopy (AFM-FS). The results showed that microparticles exhibit mucoadhesion when 
TMC is present on their surface above a threshold of TMC (>0.3% w/w).  
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INTRODUCTION 
An approach towards facing common predicaments in the field of drug delivery, while at the 
same time enhancing therapeutic efficiency, involves the exploitation of alternative routes of 
administration. The nasal route steadily claims an imperative share as route of choice during 
drug formulation development, due to circumvention of the harsh environment of the 
gastrointestinal tract, avoidance of first pass metabolism, being highly vascularised with 
increased permeability of nasal epithelium, as well as allowing ease and efficiency of 
administration.1 However nasal mucociliary clearance is one of the restraining factors limiting 
nasal drug absorption, as it diminishes the residence time of a drug formulation in the nasal 
cavity. Therefore development of mucoadhesive drug delivery systems, prolonging the extent of 
contact time between nasal mucosal epithelium and the formulation is highly desirable.2 
Chitosan, cellulose, their derivatives and alginates are the most common mucoadhesive polymers 
adopted in the development of nasal formulations.3Of particular interest is chitosan, a 
biodegradable and biocompatible polymer suitable for use in pharmaceutical formulations and 
for other biomedical applications.4On the downside, chitosan exhibits limited solubility in 
aqueous solution at physiological pH, which can be overcome by the quaternisation of its amino 
groups. The positively charged N-trimethyl chitosan (TMC) has improved solubility in neutral 
and basic aqueous media, due to the substitution of the primary amine with methyl groups, while 
at the same time exhibits excellent mucoadhesive properties.5Interactions developed between the 
negatively charged sialic acid groups of mucus substrate and the positively charged N-trimethyl 
groups of TMC are mainly responsible for attaining bioadhesiveness.6 Due to this latter property, 
TMC has been used as absorption enhancer to improve nasal delivery of macromolecules7-11 and 
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as an adjuvant associated with vaccines to enhance antigen uptake by mucosal lymphoid 
tissues.12-14 
In the current work, we developed spray-dried microparticles composed of PLGA, DPPC and 
TMC of low degree of quaternisation varying the molecular weight (low and high) and the 
amount of the derivative present in the formulations, in an attempt to “fine tune” the bioadhesive 
properties of the microparticles. 
In recent years, PLGA has become the primary synthetic polymer candidate for the development 
of microparticles due to its biocompatibility and biodegradability,15 whilst DPPC is a known lung 
surfactant and effective immunological adjuvant for nasal delivery.16 L-leucine, an excipient 
known to enhance the aerolisation properties of the dry powders17 and lactose, as bulking agent, 
were added to the formulation. 
Spray-drying is an excellent processing technique for microparticulate preparations in solid 
forms, assuring enhanced stability and improved efficacy, compared to their liquid congeners. In 
the current study, we describe a facile method of co-formulation of these three excipients by the 
spray-drying method.  
There are several studies in literature for the in vitro assessment of the mucoadhesiveness 
employing the Wilhelmy plate,18 tensiometric testing,19 ellipsometry studies,20 colloidal gold 
staining,21 the flow channel method22 and AFM.23-25 
However, there are few reports studying at the submolecular level the interactions between 
bioadhesive polymers and mucus substrate.26,27 
In the current investigation, we employed AFM-FS, to monitor the effect of polyelectrolyte 
concentration (TMC) on the bioadhesive properties of the produced microparticles. Previously it 
has been shown that the molecular weight has an effect on mucoadhesive properties of the 
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polymers up to a value of 100,000 g/mol, whereafter any further increase has no noticeable 
effect. Therefore to ensure that mucoadhesive properties are retained, molecular weights higher 
than this were selected for the starting polymers.28 
EXPERIMENTAL SECTION 
Materials.1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) was purchased from Avanti 
Polar Lipids. PLGA (ester terminated lactide:glycolide 75:25), L-leucine (reagent grade ≥ 98% 
TLC) and mucin type II were purchased from Sigma-Aldrich, Germany. A-lactose monohydrate 
was purchased from DMV International, Netherlands. Calcium chloride was purchased from 
FerakLaborat GMBH, Berlin. Potassium chloride, sodium chloride, disodium phosphate, 
potassium hydrogen phosphate and hydrochloric acid were purchased by Merck, Germany. 
Ammonium acetate was purchased from PanreacQuimica SA. Acetonitrile was purchased from 
Scharian Chemical (APHA), Spain. Acetic acid and methanol were purchased from J.T. Baker-
VWR International. Low molecular weight (LMW, 150kDa, DD 95–98%) and high molecular 
weight (HMW,600kDa, DD 75–85%) chitosans were obtained from Fluka UK. Methyl iodide 
and 1-methyl-2-pyrrolidinone were obtained from Acros Organics, Belgium.    
 
Synthesis of N-trimethylchitosan. Chitosan polymers were reductively methylated to form 
TMC polymers with low degree of quaternisation using a reaction adapted from that described 
previously.29Chitosan of both molecular weights (2 g) and sodium iodide (4.8 g) were dissolved 
in N-methyl-2-pyrrolidinone (80 mL) on a water bath at 60°C under stirring. After the chitosans 
had dissolved, the solution was kept on stirring and sodium hydroxide (11 mL, 15% w/v) and 
methyl iodide (11.5 mL) were added.  
The reaction was left on stirring for 1 h at 60°C in the presence of a Liebig condenser. The 
polymer products were then collected by precipitation with ethanol and ether and isolated by 
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centrifugation using a Jouan B4i centrifuge (Thermo Electron Corporation, Waltham, USA). The 
products were washed twice with ethanol and diethyl ether to yield N-trimethylchitosan iodide 
with a low degree of quaternisation. Ion exchange was undertaken by dissolving the product in 
sodium chloride (40 mL, 10% w/v).  
The products were again precipitated with ethanol and diethyl ether and isolated by 
centrifugation to yield a white powder, which was subsequently dissolved in deionized water (40 
mL) and filtered using a dialysis membrane to remove any residual sodium chloride. The 
solution was then freeze dried using a Modulyo Freeze dryer (Thermoelectron Corporation, 
Waltham, USA) to yield N-trimethyl chitosan chloride with low degree of quaternisation (LDQ). 
 
Characterisation of the polymer by nuclear magnetic resonance spectroscopy (NMR), 
differential scanning calorimetry (DSC) and Fourier transform infrared (FT-IR) 
spectroscopy. NMR was used to characterize the synthesized TMC polymers. The 1H-NMR 
spectrum was recorded in D2O with a Bruker 600 MHz spectrometer (Bruker, Faellanden, 
Switzerland) at 80°C. Minimum interference was observed from the water peak at this 
temperature and suppression of the water peak was not necessary.  The degree of quaternisation 
of TMC polymers from the 1H-NMR spectra was calculated from Eq. 1, 
 
DQ (%) = [(TM/H) x 1/9] x 100 (1) 
 
where DQ (%) is the degree of quaternisation expressed as a percentage, TM  is the integral of 
the trimethyl amino group peak (CH3N+), and H is the integral of the 1H peaks. 
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Thermal analysis of the samples was carried out with a DSC instrument (DSC 204 F1 Phoenix, 
NETZSCH) under a nitrogen purge of 70 mL/min and heating rate of 10oC/min. Aluminum 
crucibles with pierced lids were loaded with 4 mg of each sample and heated at the temperature 
range of 20 – 350oC. 
Infrared spectra were obtained with an IR Prestige-21(Shimadzu) instrument at a resolution of  2 
cm-1 and over a frequency range of 650 - 4000 cm-1. 
 
Preparation of the spray-dried microparticles. Five different formulations were developed 
using the spray-drying technique, consisting of PLGA: DPPC: L-leucine : α-lactose monohydrate 
(ESI: Figure S1, chemical structures of all excipients) in a ratio of 32 : 8 : 3.2 : 56.8 (w/w) and 
varying the concentration of TMC from 0 to 0.5% with adjustment of the amount of α-lactose 
accordingly. The total solid was 375 mg, corresponding to a concentration of 0.47% (w/v) in the 
feed solution. All formulations were prepared twice with a yield ranging from 27.88 up to 
38.08%. 
The feed solution was prepared by dripping 50 mL of the organic phase (acetonitrile) containing 
DPPC and PLGA to 30 mL of the aqueous phase, consisting of TMC, L-leucine and α-lactose 
monohydrate, under continuous magnetic stirring and heating at 70oC to avoid precipitation of 
DPPC. All constituents were completely dissolved prior to spray drying.  
The resulting clear solution was immediately spray-dried using a mini spray-drier (Büchi-
MiniSprayDryerB-191, Büchi, Switzerland) under continuous magnetic stirring and heating at 
70oC. The total mass of solids in feed solution was kept to 0.47% w/v in all cases. The solutions 
were pumped in the drying chamber at a feed pump rate of 25% (8.5 mL/min).The inlet 
temperature was set at 90oC, the airflow at 600 L/h, the aspirating setting level at 100% and as a 
 9
result the outlet temperature varied between 59oC and 63oC. The collected powders were stored 
in a desiccator containing anhydrous CaCl2 prior to examination. 
 
Scanning electron microscopy (SEM) and image analysis of the microparticles. The 
morphology of the particles was assessed by means of SEM. Specimens were mounted on 
metallic sample stands using conductive adhesive tape (PELCO Image Tabs) and gold sputtered 
under high vacuum (~5×10-2 mbar) using a BAL-TECSCD-004 sputtering unit.  
Mean particle size and particle size distribution were determined by analyzing100 randomly 
selected individual particles from 3 different SEM images by means of ImageTool software 
(UTHSCSA,Version 3.00). 
 
ζ-potential studies. The electrical properties of the particles were further assessed by ζ-potential 
measurements using a Zetasizer Nanoseries, Nano-ZS analyzer (Malvern, UK). Appropriate 
amounts of particles were dispersed in SNES solution (NaCl 7.45 g/L, KCl 1.29 g/L and 0.32 
mg/L CaCl2) pH 5.5 adjusted with HCl and subjected to sonication for 10 seconds, to enable 
sufficient dispersion. Measurements were repeated in triplicate. 
 
Deposition of the microparticles to AFM cantilevers. Force spectroscopy experiments were 
conducted by means of atomic force microscopy (AFM) using an MFP3D  system (Asylum 
research, Santa Barbara, CA, USA) in a liquid environment, using simulated nasal electrolyte 
solution, SNES, at pH 5.5 as liquid medium. First AFM cantilever spring constants 
(HQ:CSC37/TIPLESS/NO AL, nominal spring constant range 0.10 N/m – 0.60 N/m; μmasch, 
Sofia, Bulgaria) were experimentally determined using the thermal noise method, with 
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determined spring constants being in the range of 0.15 N/m - 0.30 N/m. Subsequently, the 
microparticles were glued onto tipless AFM cantilevers using epoxy glue (Araldixe®, Selleys, 
Padstow, Australia) as following:  
A droplet of few micro-litres of the epoxy was deposited onto a freshly cleaned microscopy 
glass-slide. By its side, a small amount of the particle-powder was spread and the slide was 
placed onto the AFM stage, as if it was to be imaged. The cantilever was then engaged in 
contact-imaging mode onto the epoxy droplet, pulled out of it and engaged again onto the 
particles. After 1 min, the cantilever was withdrawn and stored in a shielded container until the 
epoxy was set. Finally, before the measurement, the cantilever was thoroughly washed with 
ultrapure water to remove any particles that were not firmly attached to the epoxy. 
Prior to force spectroscopy measurements, the functionalised AFM cantilevers were inspected 
under polarised microscope (Alicona® infinite focus microscope) and the coverage area was 
measured in ImageJ (v1.48, National Institute of Health), after manually segmenting the areas 
where microparticles were present (ESI, Figure S2). 
 
Mucin coating of glass substrates. The protocol for the fixation of mucin onto the glass with 
the epoxy was previously described by Cleary et al.30 In brief, after mixing the epoxy, a thin 
layer of the adhesive was spread onto the centre of the glass bottom of the fluid cell and left 
undisturbed until a smooth surface was formed (ca.30 - 40 s). At this stage, a generous amount of 
lyophilised mucin was spread onto the epoxy; the fluid cell was covered for protection from dust 
particles and left overnight to set. The next day, the fluid cell was thoroughly washed with 
ultrapure water to remove any mucin polymers that were not firmly attached to the epoxy.  
 
 11
Force spectroscopy experiments. With each functionalized cantilever, 30 force curves were 
collected from the same spot of the glass slide to avoid variations of the measured detachment 
behavior, due to variations of mucin concentration underneath the AFM cantilever. Prior to this, 
approximately 10 -20 force curves were taken on a random spot to remove any weakly attached 
microparticles from the cantilever, ensuring that all force curves measured there after correspond 
to the detachment of firmly attached microparticles from the mucin.  
For each force curve, the AFM cantilever was retracted 3μm away from the surface, then 
approached towards the surface and brought in full contact with it, i.e. approach was stopped 
upon reaching a loading force of 5 mN, (ESI, Figure S3). After a dwell time of 10 sec at this 
force, the cantilever was retracted back to the starting position. During this cycle, both the 
approaching and the retraction velocities were set to 1.0 μm/sec. For data analysis, measured 
forces of all features were normalised against the microparticles’ coverage area on the lower side 
of the cantilever.  
 
Statistical analysis. The significance of the difference of the means between the different 
formulations was calculated in OriginPro 9.0.0 (Origin Lab Corporation, Northampton, MA, 
USA) by means of one way ANOVA. The means between the different groups were compared 
using Bonferroni’s mean comparison method as implemented in the software.  
 
 
RESULTS AND DISCUSSION 
Physicochemical characterisation of trimethylchitosan 
NMR studies.The degree of quaternisation of the polymers was measured using equation 1 
described previously, by identifying (CH3)3 and H peaks. This was calculated to be 16% for the 
TMC LMW and 27.5% for the TMC HMW (ESI, Figure S4). The peaks at 3.8 and 2.57 ppm are 
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assigned to the hydrogen of quaternary and tertiary amino groups respectively.28 The 1H peaks 
fall between 5.1 and 6.1 ppm. 
DSC studies. The thermograms of TMC LMW and HMW (Figure 1A) revealed a wide 
dehydration peak in the range of 40 - 130oC and 50 - 150oC respectively and an exothermic peak 
at 230oC corresponding to combustion of the sample.31 
FT-IR studies. The FT-IR spectra of TMC HMW and LMW spectra are presented at Figure 1B. 
The following peaks can be identified: a band at 1050 cm-1 due to C-O bond, the characteristic 
bending band at 1465 cm-1 and stretching band at 2916 cm-1 of the C-H bond, a weak band at 
1640 cm-1 that could be assigned to C=O vibration of the acetamide group (due to partial 
deacetylation of TMC) and a broad peak in the range of 3300 - 3500 cm-1, due to the vibration of 
the hydrogen bonded -NH2 and -OH.32 
 
Characterisation of the spray-dried microparticles 
ζ-potential measurements. Plain microparticles exhibit the lowest charge value (-14.29 ± 2.54 
mV), as a result of the presence of the negatively charged -COOH functional groups of PLGA, as 
shown in Figure 2. An increase in TMC concentration from 0 to 0.3% w/w resulted in a decrease 
of ζ-potential, in absolute values, to - 8.54 ± 3.21 and - 4.97 ± 2.01 mV for 0.3% w/w LMW and 
HMW respectively.  
Further addition of the polyelectrolytes at a concentration of 0.5% w/w shifted the ζ-potential 
values towards their isoelectric point (0.703 ± 1.27 mV and 0.985 ± 0.96 mV for LMW and 
HMW respectively). This observation might imply the presence of the polyelectrolyte on the 
surface of the particles. Molecular weight of TMC doesn’t seem to influence ζ-potential, being in 
agreement with previous studies.33 
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SEM studies. Representative SEM images of the microparticles are illustrated in Figure 3. SEM 
visualization revealed the formation of spheroid particles with a coarse surface and mean 
diameters ranging from 2.11 - 2.77 μm. On several occasions the microparticles appeared 
stacked to each other, which might be attributed to the weak electrostatic repulsions among them, 
as evident from their low surface charge. 
AFM studies. The adhesion strength measurements for the different formulations are shown in 
Figure 4A, while the relation between the molecular weight of the polymers versus the 
detachment distance is presented in Figure 4B. Increased adhesion strength values were recorded 
with increased TMC concentration for both molecular weights. This should be attributed to the 
formation of additional mucin-TMC bonds, which in turn enhance the adhesion strength. 
Increase in molecular weight of TMC resulted in reduction of the adhesion strength values, as 
evident from Figure 4A and significant increase of detachment distance (Figure 4B). 
As expected, the longer HMW TMC molecules are able to stretch, uncoil and reveal hidden 
length34during the cantilever retraction, maintaining attachment between particle and mucin at 
longer distances compared to the LMW TMC-mediated attachment. 
Furthermore, because the HMW TMC molecules are longer than the LMW ones, bonding 
between HMW TMC and mucin can occur at a great number of sites along the TMC chain. This, 
at a given retraction distance, results in fewer molecules being stretched simultaneously since, 
during retraction, a TMC molecule bonded to mucin via a bonding site located at the end of its 
polymer chain will be stretched later than some other, which is bonded via a bonding site close to 
the middle of its chain. 
Given now that the adhesion strength is defined as the maximum registered adhesion force at a 
given time, fewer simultaneously stretched molecules will result in lower adhesion strength. 
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This can be further exemplified in Figure 4C, when comparing the force-curves of the 0% w/w 
TMC with both the 0.3% and 0.5% w/w TMC formulations. The detachment behaviour of the 
0% TMC formulation is dominated by a single sharp peak very close to the surface of the mucin, 
which corresponds to the simultaneous rupture of a high number of the weak - short range bonds, 
mainly electrostatic, that have been formed between the particles’ surface and the mucin 
molecules. Addition of low concentration of TMC on the surface of the microparticles induces 
the formation of some new bonds between the mucin and the polyelectrolyte molecules, but at 
the same time the TMC interacts with the DPPC and PLGA molecules, neutralising many of the 
previously active bonding sites. 
Mucoadhesion of TMC is due to interactions developed between its positively charged groups 
and the negatively charged sialic acid or sulfuric acid residues of the mucosal linings.35 Because 
of the length of chitosan molecule, these bonds are getting stretched – and eventually break – in 
greater distance from the surface. Thus, during cantilever retraction fewer bonds are 
simultaneously stretched resulting in a lower adhesion strength, but at the same time attachment 
of the particle onto the mucin is maintained for a longer distance via the newly formed TMC-
mucin bonds (cf. Figure 4). In contrast, higher concentration of TMC introduces a higher number 
of bonding sites, which, as mucin cannot anymore interact with the already saturated DPPC and 
PLGA molecules, remain ‘active’ to interact with the mucin. Consequently, a greater number of 
TMC-mucin bonds are formed resulting in higher adhesion strength. When these bonds break, 
the hidden length of TMC molecules protrude to the surface and sequential breaking up of the 
TMC-mucin bonds occurs. This results in the smaller “saw tooth”- like peaks27observed after the 
main peak (cf. Figure 4C, and insets in 4A and 4B). 
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Finally, it is worth noting that the detachment distance is independent of the TMC concentration 
and only depends upon the molecular length of the TMC, resulting in identical detachment 
distances for both concentrations of the same type of TMC (Figure 4B). 
The detachment energy is illustrated in Figure 5.  The data show that the presence of 0.5% w/v 
TMC increases significantly the energy required for the detachment of the cantilever from the 
mucus surface, compared to that of the 0% and 0.3% w/w TMC. Interestingly, the detachment 
energy between the 0% and 0.3% w/w TMC modified microparticles appears to be similar 
suggesting a threshold of minimum TMC concentration, above which the secondary chemical 
bonds of TMC with the mucus surpass the non-specific interactions, such as hydrogen bonding 
and electrostatic interactions, between PLGA and the mucin.  
The molecular weight of TMC is also affecting the adhesion of the particles onto the mucus. The 
high molecular weight (HMW) TMC molecules are able to extend and stretch more during 
cantilever retraction before bond breakage, compared to the low molecular weight (LMW) ones. 
In a way, the HMW TMC molecules act as long anchors between the particle and the mucin, 
resulting in longer pulls (Figure 5) and consequently higher detachment energy. 
The results presented in Figure 5 are in broad agreement with the ζ-potential values, where the 
surplus charge, due to the presence of the polyelectrolyte at higher concentrations (0.5% w/w), 
might increase the attractive forces between the microparticles and the substrate. Such 
electrostatic interactions result in increased values of the adhesion strength and the detachment 
energy for the 0.5% w/w concentrations of TMC.  
Similar results were obtained by Li et al.27 when the interaction of PLGA and chitosan (CS) of 
low molecular weight and mucin was investigated by AFM and interpreted in terms of the 
hydrophobic/hydrophilic balance of their interface. The force of adhesion between the PLGA/CS 
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coated tip and the mucin became attractive at CS concentration of 0.2% (w/v).27 These 
observations are in broad agreement with the findings of the current study, where increased 
values of the detachment energy are achieved above the threshold of 0.3% w/w of TMC 
concentration. 
TMC concentration seems to play a role above the threshold of 0.3% w/w of TMC, with the 
higher DQ polymer (HMW) exhibiting better bioadhesive properties (Figure 5). 
This is consistent with the findings of Hammanet al.36, where the in vivo absorption of [14C]-
mannitol to a rat model was increased with an increase in the degree of quaternisation of TMC 
up to 48%. 
The effect of degree of quaternisation and molecular weight of TMC has been investigated for 
the buccal delivery of a model compound in vitro37and the transcorneal permeation of ofloxacin 
both in vitro and in vivo.38The mucoadhesive properties of the polymers increased by increasing 
the degree of quaternisation,37 whereas unlike the in vitro experiments the in vivo studies showed 
the superiority of the high molecular weight TMC.38 
 
CONCLUSIONS 
In the current study, N-trimethyl chitosan chloride containing microparticles comprised of DPPC 
and PLGA were prepared by the spray-drying method. Changes in the composition of the 
microparticles had little effect on their size, whereas their surface charge increased as a function 
of TMC concentration. By enrolling atomic force microscopy - force spectroscopy (AFM-FS) 
important information could be obtained for the mucoadhesive properties of the polymers at the 
submolecular level. This method is powerful for probing specific events at the molecular level, 
providing a deeper insight into the molecular nature of the adhesion mechanism. Because of the 
small tip size, which can only host a limited number of particles, a small number of binding sites 
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are exposed to the substrate and thus a small number of molecular pairs can be formed and 
probed at a given time. This, along with the fact that AFM-FS experiments can be performed in 
conditions that emulate the in-vivo environment (i.e. in liquid, under controlled chemical 
environment, pH and temperature), renders this technique as an excellent alternative to 
techniques that rather assess the overall adhesion properties without the ability to resolve 
individual molecular events (e.g. Wilhelmy plate method). 
Bioadhesive studies revealed that there is a threshold of TMC concentration (>0.3% w/w) 
present in the microparticles to allow adhesion with mucus and that higher concentration of TMC 
and higher molecular weight TMC molecules both lead to higher adhesion detachment energies. 
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FIGURE LEGENDS 
Figure 1: (A) DSC thermograms of LMW and HMW TMC (B) FT-IR spectra of LMW and 
HMW TMC. 
 
Figure 2: Size and ζ-potential values of the microparticles.The microparticles were ranging from 
2.11 up to 2.77 μm for all formulations tested. The ζ-potential of the formulations was shifted  
towards lower values as a function of TMC concentration. 
 
Figure 3: SEM images of PLGA-DPPC microspheres containing:  (A) 0.3% w/w LMW TMC,  
(B) 0.5% LMW TMC (C) 0.3% HMW TMC, (D) 0.5% HMW TMC and (E) 0% TMC.(Figure 
insets: Size distribution histograms of microparticles were generated from SEM image analysis) 
 
Figure 4: (A) Adhesion strength (B) Detachment distance (C) Representative force curves 
obtained using PLGA/DPPC particles with different concentrations of high- (HMW) and low- 
(LMW) molecular weight TMC. On the box plots shown, the centre of the notch shows the 
median and the semi-filled circle the mean of the distribution. Whiskers represent +S.D. and –
S.D. and the box’s lower and upper boarder the lower 25 % and upper 75 %. The notch around 
the median represents the ‘confidence interval’ for the median. In principal, when the notches of 
two box plots do not overlap, the medians difference can be considered significant (significance 
level =0.05). 
 
Figure 5: Detachment energy values of microparticles varying the concentration of LMW and 
HMW TMC. On the box plots shown, the centre of the notch shows the median and the semi-
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filled circle, the mean of the distribution. Whiskers represent +S.D. and –S.D. and the box’s 
lower and upper border the lower 25 % and upper 75 %. The notch around the median represents 
the ‘confidence interval’ for the median. In principal, when the notches of two box plots do not 
overlap, the medians difference can be considered significant (significance level =0.05). 
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FIGURE 2 
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FIGURE 3
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FIGURE 4 
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FIGURE 5 
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